Research groups
Research at the Division of Pharmaceutical Biosciences is performed in a number of research groups and often in close collaboration with national and international laboratories or pharmaceutical companies.
Research groups in pharmaceutical biosciences

Research groups that operate wholly or partly under the Division of Pharmaceutical Biosciences in alphabetical order.


Bioactivity Screening
Group Leader Päivi Tammela
We are experts in antimicrobial drug discovery, exploring new ways to confront the global challenge of emerging drug resistance amongst bacteria.

Group leader Marjo Yliperttula

The focal point of Biopharmaceutics group research is the development of the biomaterials for cell culture, drug delivery, and tissue repair together with the relevant detection technology. The developed materials are based on the nanofibrillated cellulose, nanoparticles, and extracellular vesicles.


Drug Delivery Unit
Group Leader Arto Urtti
Optimal delivery of drugs to their target sites is essential for drug efficacy and safety. Drug delivery unit explores the key pharmacokinetic factors in drug delivery as well as new technologies for delivering drugs, especially to the eyes.


ImmunoViroTherapy Lab
Group Leader Vincenzo Cerullo
Development of novel platforms for cancer immunotherapy.


Lymphangiogenesis Research and Antibody Development
Group Leader Michael Jeltsch

We do biomedical research in vascular biology (lymphangiogenesis, VEGF-C) and antibody technology development.


Phar­ma­ceut­ical nanotechnology
Group Leader Timo Laaksonen
We work on controlled drug release and delivery using modern methods and materials.


See also Drug Research Program Units

Drug Research Program (DRP) is a unique multidisciplinary platform that combines research groups with expertise on different aspects of drug research.